Global Neurodiagnostics Market 2024-2028
The neurodiagnostics market is forecasted to grow by USD 4,042.13 mn during 2023-2028, accelerating at a CAGR of 8.01% during the forecast period. The report on the neurodiagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of neurological disorders, the growing geriatric population, and rising funding for neurology research.
Technavio's neurodiagnostics market is segmented as below:
By Type
- Diagnostic and imaging solutions
- In-vitro diagnostics
By End-user
- Diagnostic laboratories and imaging centers
- Hospitals and surgery centers
- Others
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing focus on accurate neurological diagnostics as one of the prime reasons driving the neurodiagnostics market growth during the next few years. Also, rising initiatives and support from governments and healthcare organizations and growing medical tourism in emerging economies will lead to sizable demand in the market.
The report on the neurodiagnostics market covers the following areas:
- Neurodiagnostics market sizing
- Neurodiagnostics market forecast
- Neurodiagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurodiagnostics market vendors that include Advanced Brain Monitoring Inc., ANT Neuro, Bio Signal Group Corp., Cadwell Industries Inc., Canon Inc., Compumedics Ltd., ELMIKO BIOSIGNALS sp. z o.o., F. Hoffmann La Roche Ltd., FUJIFILM Corp., General Electric Co., Jordan NeuroScience, Koninklijke Philips N.V., Lifelines Neuro Company LLC, Mitsar Co. Ltd., Natus Medical Inc., neurocare group AG, Nihon Kohden Corp., NovaSignal Corp., QIAGEN NV, and Siemens Healthineers AG. Also, the neurodiagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.